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Background: There is a paucity of diagnostic and therapeutic facilities in Nigeria to confirm coronary artery disease
and offer appropriate interventional therapy. There is now a private cardiac catheterization laboratory in Lagos but
as there are no sustained Open Heart Surgery programmes, percutaneous coronary interventions are currently
being performed without surgical backup. This study was designed to assess results of stand-alone percutaneous
coronary intervention (PCI) as currently practiced in Lagos, Nigeria.
Methods: This cross-sectional study was conducted between July 2009 and July 2012. The study included all
patients that underwent PCI in Lagos. Data was extracted from a prospectively maintained database.
Results: Coronary artery disease was confirmed in 80 (52.6%) of 152 Nigerians referred with a diagnosis of Ischaemic
Heart Disease. There were 53 males (66.2%) and 27 females (33.8%). The average age was 60.3 +/−9.6 years and
average euroscore was 4.5 +/−3.1. Of the 80 patients, 77 (96.3%) had significant stenoses and were candidates for
revascularization. Distribution of significant stenoses was one in 32 patients (41.5%), two in 11 patients (14.3%),
three in 19 patients (24.7%), four in 13 patients (16.9%) and five in 2 patients (2.6%). PCI was performed in 48
(62.3%) of the patients eligible for revascularization as the coronary anatomy in the remaining patients was not
suitable for PCI. The indication for PCI was for myocardial infarction or unstable angina in 39 patients (81.2%). PCI
was performed with PTCA plus stenting in 41 patients (85.4%) and with PTCA alone in 7 patients (14.6%) with
good angiographic results. Overall 29 of the 48 patients (60.4%) had complete revascularization of significant
stenoses. Complications of PCI were bleeding that required blood transfusion in 1 patient (2.1%), minor femoral
haematomas in 2 patients (4.2%), and a major adverse clinical event in 1 patient (2.1%).
Conclusion: A stand-alone PCI programme has been developed in Lagos, Nigeria. Both elective and urgent PCIs
have been performed with no mortalities and a low complication rate. Increased volumes will however accrue and
complete revascularization rates would be improved with the establishment of Open Heart Surgery programmes
to provide CABG as back-up for PCI and alternate therapy for more complex lesions.Background
Initially thought to be very uncommon in the West
African population, it has been noted that there is now
a rising incidence of coronary artery disease [1-5]. There
has unfortunately been a paucity of diagnostic and inter-
ventional facilities in most West African countries, includ-
ing Nigeria. Efforts are ongoing to establish such facilities
in Nigeria but there are challenges to establishing these* Correspondence: yemi@firstcardiologyconsultants.com
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stated.services and making them sustainable [6-9]. There is cur-
rently no Open Heart Surgery (OHS) programme in
Nigeria with sustained activity.
There has been some progress in the private sector in
Nigeria, with the establishment of private cardiac cathe-
terization services in Lagos (Reddington Multispecialty
Hospital). Additionally, a private diagnostic facility has
also been established in Lagos (First Cardiology Consul-
tants). With the advent of these services, patients sus-
pected of having Ischaemic Heart Disease (IHD) are being
referred to First Cardiology Consultants (FCC) and where
coronary angiography is indicated as part of the cardiacl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Distribution of significant coronary stenoses and
percutaneous coronary interventions
Vessel Stenosis SS (%) PTCA BMS DES PCI total
(% of SS)
LMS 9 9 (100) - - 3 3 (33.3)
LAD Proximal 45 41 (91.1) 1 12 7 20 (48.8)
LAD Mid 24 22 (91.7) 2 2 8 12 (54.5)
LAD Distal 3 2 (66.7) - - - -
Diagonal 8 8 (100) - - 1 1 (12.5)
Cx Proximal 24 20 (83.3) 1 1 2 4 (20)
Cx Mid 13 9 (69.2) - 6 - 6 (66.7)
Cx Distal 6 3 (50) 1 1 1 3 (100)
OM1 12 7 (58.7) 1 - - 1 (14.3)
OM2 3 2 (66.7) - - - -
Intermediate 4 3 (75) - - 1 1 (33.3)
RCA Prox 27 21 (77.8) 3 2 8 (38.1)
RCA Mid 14 13 (92.8) 2 5 1 8 (61.5)
RCA Distal 7 5 (71.4) 1 1 1 3 (60)
PDA 4 3 (75) 1 1 - 2 (66.7)
PLB 4 3 (75) - - - -
Total 207 171 (82.6) 13 32 27 72 (42.1)
LAD: Left Anterior Descending Coronary Artery. Cx: Circumflex Coronary Artery.
RCA: Right Coronary Artery. OM: Obtuse Marginal Coronary Artery. PDA:
Posterior Descending Coronary Artery. PLB: Posterolateral branch of Right
Coronary Artery. SS: Significant Stenosis. PTCA: Percutaneous Transluminal
Coronary Angioplasty. BMS: Bare Metal Stent. DES: Drug Eluting Stent. PCI:
Percutaneous Coronary Intervention.
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suite at the Reddington Multispecialty Hospital (RMH).
Without the support of Open Heart Surgery pro-
grammes in Nigeria difficult choices need to be made
when patients that present with Ischaemic Heart Disease
are found to have significant coronary artery disease.
Where Percutaneous Coronary Intervention PCI is per-
formed, this currently has to be done without surgical
back-up.
The aim of this study was to describe the results of
stand-alone PCI as currently practiced in Nigeria.
Methods
The study population was all patients that underwent
Cardiac catheterization at RMH as part of cardiac evalu-
ation for IHD. Usual vascular access was via the right fem-
oral artery. Coronary Ostia were cannulated and contrast
injected to image and assess the coronary arteries to deter-
mine if intervention was required. Vessels that had tight
ostial stenosis or were heavily calcified were deemed un-
suitable for PCI and were referred abroad for Coronary
Artery Bypass Grafting (CABG). Where the vessels were
diffusely diseased the patients were continued on medical
therapy. Major epicardial vessels or their branches with
stenosis >70% or Left Main Stem Stenosis >50% were
defined as significant stenoses which would require
intervention [10]. These vessels underwent PCI with
PTCA ± stenting. Stents used were either Drug Eluting
Stents or Bare Metal Stents. Following PCI, the patients
were monitored overnight in the high dependency unit
to exclude any complications, prior to discharge home.
Following approval by the ethical committee of FCC
data was extracted from a prospectively maintained data-
base. The study period was from July 2009 till July 2012.
The data extracted for analysis was that of Nigerian pa-
tients referred with a diagnosis of suspected IHD who
went on to have cardiac catheterization and coronary
angiography as part of their evaluation. Extracted data
included patient demographics, euroscore, indication
for cardiac catheterization, distribution and severity of
coronary stenoses, type of PCI performed completeness
of revascularization, result of PCI and complications seen.
Data analysis was performed with Microsoft Excel 2010
and results are expressed as numbers, mean ± standard
deviation or percentages as appropriate.
Results
152 Nigerians were referred with a diagnosis of IHD of
which 80 were confirmed at coronary angiography to have
Coronary Artery Disease (CAD). These 80 patients with
confirmed CAD were the focus of this study. The sex dis-
tribution of patients with CAD was 53 males (66.2%) and
27 females (35.3%). The average age was 60.3 +/− 9.6 years.
The average euroscore was 4.5 +/− 3.1.The 80 patients with CAD had a total of 207 coron-
ary stenoses, of which 171 (82.6%) were significant
stenoses >70% (Table 1). These significant stenoses oc-
curred in 77 patients (96.3%) who were therefore can-
didates for coronary revascularization. Distribution of
the significant stenoses in these 77 patients showed one
significant stenosis in 32 patients (41.5%), two significant
stenoses in 11 patients (14.3%), three significant stenoses
in 19 patients (24.7%), four significant stenoses in 13
patients (16.9%) and five significant stenoses in 2
patients (2.6%).
PCI was performed in 48 patients (62.3%) but 29 pa-
tients (37.7%) did not have PCI. Of the 29 patients that
did not have PCI, 28 (96.6%) had coronary anatomy un-
suitable for PCI, while 1 patient (3.4%) had a pacemaker
implanted for complete heart block. The indications for
PCI are shown in Table 2. This shows that 39 of the 48
PCIs performed (81.2%) were for patients presenting
urgently with myocardial infarction or unstable Angina.
For the 48 patients that underwent PCI, 22 patients
(45.8%) had one significant stenosis, 6 patients (12.5%)
had two significant stenoses, 14 patients (29.2%) had
three significant stenoses, 5 patients (10.4%) had four sig-
nificant stenoses and 1 patient (2.1%) had five significant
stenoses. Analysis of the completeness of revascularization









Indication 31 20 20 5 1 77
PCI 25 14 7 2 0 48
%PCI 80.6 70 35 40 0 62.3
STEMI: ST elevation myocardial Infarction. NSTEMI: Non-ST elevation
myocardial infarction. UA: Unstable Angina. CCF: Congestive Cardiac Failure.
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complete revascularization was achieved in 100% of
patients with single stenosis, 50% of patients with two
stenoses, 21.4% of patients with three stenoses, 20% of
patients with four stenoses and 0% of patients with five
stenoses (Table 3). Overall 29 of the 48 patients (60.4%)
had complete revascularization.
PCI was performed by PTCA plus stenting in 41 pa-
tients (85.4%) and PTCA alone in 7 patients (14.6%). A
total of 59 stents were used, with 32 (54.2%) being Bare
Metal Stents and 27 (45.8%) being Drug Eluting Stents
(Table 1).
Complications of PCI were bleeding that required
blood transfusion in 1 patient (2.1%), minor femoral hae-
matomas in 2 patients (4.2%), and a major adverse clinical
event (MACE) in 1 patient (2.1%). The patient with MACE
presented in shock from acute coronary syndrome and
preoperative intra-aortic balloon pumping was instituted
for LV assist. At cardiac catheterization a lesion in the
RCA could not be crossed and the artery was unfortu-
nately dissected. The patient was transferred urgently to
a centre in Lagos for CABG which was performed with
a reversed saphenous vein graft to the RCA but the
patient died of progressive right ventricular failure [8].
Discussion
In the early days of PCI there was a mortality rate of 1–
2.5% and 1.9-5.8% of patients would proceed to emergency
CABG [11-13]. Over the intervening years, as practice has
improved, both the mortality rate and patients proceeding
to emergency CABG is now <0.4% [14]. PCI is therefore
now much safer and the indications for PCI extend toTable 3 Distribution of patients having PCI by the number of
One SS Two SS
PCI to One Stenosis 22 3
PCI to Two Stenoses - 3
PCI to Three Stenoses - -
PCI to Four Stenoses - -
PCI to Five Stenoses - -
Total PCI performed 22 6
% complete revascularization 100 50
PCI: Percutaneous Coronary Intervention. SS: Significant Stenosis.both patients with chronic stable angina as well as patients
with myocardial infarction and acute coronary syndrome
[14-16]. The growth in PCI has been in tandem with the
growth in Open Heart Surgery programmes such that the
choice of PCI or CABG can be made for the individual pa-
tient on the basis of presentation and the type of coronary
lesions found. Referrals for elective as well as emergency
CABG have subsequently dropped as PCI programmes
have developed and are showing improving results [17,18].
The Achilles’ heel of PCI in the early days was a high
restenosis rate [19] but careful patient selection and
the development of Drug-Eluting stents has markedly
reduced restenosis rates [20,21]. This has gradually
made PCI the first choice for coronary revasculariza-
tion for suitable coronary lesions [22].
Though the complications of PCI that would require
emergency CABG have been reduced to a minimum in
high volume centers, they do occur and it has been ad-
vised that PCI programmes should run alongside CABG
programmes to prevent undue delay in the event of com-
plications [23,24]. PCI and CABG programmes often co-
exist in the same institution but this is not always the case,
especially in rural areas where resources are more limited.
This has therefore led to the debate as to whether stand-
alone PCI programmes should be encouraged or whether
the envelope is being pushed too far [25]. This debate con-
tinues and various guidelines have been released in different
countries to guide the practice and obtain the best out-
comes for patients. Most of the guidelines recommend that
standalone PCI programmes should be within 5 minutes of
a CABG programme and should be run by a high volume
operator who is experienced in determining whether coron-
ary stenoses are suitable for PCI or should be referred for
CABG [23,25]. The 2005ACC/AHA/SCAI PCI guidelines
recommended that primary PCI for STEMI should be
performed by high volume operators experienced in both
elective PCI and primary PCI for STEMI with ongoing
activity levels of greater than 75 elective PCI a year and
ideally annual PCI for STEMI of at least 11 a year [22].
Where do things stand in a developing country like
Nigeria? The development of Open Heart Surgery and
Cardiac Catheterization has been very slow in light of thesignificant stenoses
Three SS Four SS Five SS Total
6 1 - 32
5 1 1 10
3 2 - 5
- 1 - 1
- - - -
14 5 1 48
21.4 20 0
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has developed in fits and starts and there is currently no
programme in Nigeria with regular sustained activity.
Similarly, there has been no Cardiac Catheterization for
several years till the advent of the laboratory at RMH in
Lagos. In light of the absence of Open Heart Surgery sup-
port, should a Cardiac Catheterization facility be devel-
oped without the back-up of the possibility of emergency
CABG? The findings from this study would suggest that
there is certainly a place for stand-alone PCI in Nigeria.
The first author was a high volume operator in practice in
the US with an excess of 500 PCI cases annually including
elective PCI and PCI for STEMI. Of the 77 patients with
significant stenoses, 48 patients (62.3%) were selected as
having lesions suitable for PCI. Over 80% of the PCI were
performed for urgent cases with Myocardial Infarction
and Unstable Angina. The complication rate was low with
only one patient having MACE and there were no mortal-
ities from PCI. The majority of patients undergoing PCI
(85.4%) received stents of which Drug Eluting Stents was
almost 50%.
Analysis of the results however underlines the urgency
in pushing the concomitant development of Open Heart
Surgery to make the option of CABG available so that
patients with IHD and significant coronary stenoses can
have the best outcomes. The choice of the best option for
the patient can then be made on the basis of complexity of
the lesion as obtains in the Western World. Out of the 77
patients found to have significant stenoses at coronary
angiography, 28 patients (36.4%) had lesions too complex
for PCI and had to be referred abroad for CABG. Al-
though 48 patients underwent PCI, only 29 (60.4%) had
complete revascularization. Of 171 stenoses identified
as being significant, only 72 (42.1%) underwent PCI. All
of the patients with single stenosis underwent PCI but
the revascularization rate reduced as the number of sig-
nificant stenoses increased. It is likely that the revasculari-
zation rate would have been considerably higher if an
Open Heart Surgery Programme was available as those pa-
tients with more complex lesions would have also received
surgical intervention. It has been suggested that PCI is an
effective treatment for patients with multivessel disease
without the need to dilate all diseased vessels with a rea-
sonable expectation of satisfactory long-term clinical im-
provement [19] but this remains to be confirmed on
follow up of this cohort of patients. The recently published
results of the SYNTAX Trial [26] indicate that CABG re-
sults in reduced MACCE for coronary lesions with inter-
mediate and high SYNTAX scores, whereas for lesions
with low SYNTAX scores PCI is a good alternative as
there is no difference in MACCE compared to CABG.
There are currently no other centres in West Africa
offering PCI services. Volumes of PCI reported in this
study were low as this reflects a new, developing servicein Nigeria. Increased awareness of the existence of this
service is already resulting in more referrals from physi-
cians. In addition, the volumes were low due to careful
case selection in the absence of back-up Open Heart
Surgery services.
Conclusion
A stand-alone PCI programme has been developed in
Lagos, Nigeria. Both elective and urgent PCIs have been
performed with no mortalities and a low complication
rate. Increased volumes will however accrue and complete
revascularization rates would be improved with the estab-
lishment of Open Heart Surgery programmes to provide
CABG as back-up for PCI and alternate therapy for more
complex lesions.
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